Scott Bowden

Summary

Affiliation: Royal Melbourne Hospital
Country: Australia

Publications

  1. ncbi request reprint Hepatitis B: the case for combination therapy
    Scott Bowden
    Victorian Infectious Diseases Reference Laboratory, 10 Wreckyn Street, North Melbourne, Victoria 3051, Australia
    Curr Opin Investig Drugs 10:795-803. 2009
  2. pmc Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
    Anchalee Avihingsanon
    The Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, Australia
    AIDS Res Ther 9:6. 2012
  3. ncbi request reprint New hepatitis viruses: contenders and pretenders
    S Bowden
    Victorian Infectious Diseases Reference Laboratory, North Melbourne, Australia
    J Gastroenterol Hepatol 16:124-31. 2001
  4. pmc New developments in HBV molecular diagnostics and quantitative serology
    D Scott Bowden
    Victorian Infectious Diseases Reference Laboratory, North Melbourne, Vic, Australia
    Hepatol Int 2:3-11. 2008
  5. ncbi request reprint Chronic hepatitis C virus infection: genotyping and its clinical role
    D Scott Bowden
    Victorian Infectious Diseases Reference Laboratory, and Department of Microbiology, Monash University, Clayton, Carlton South, Victoria, Australia
    Future Microbiol 1:103-12. 2006
  6. doi request reprint Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia
    Tin Nguyen
    Department of Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory, North Melbourne, Vic, Australia
    J Hepatol 52:508-13. 2010
  7. ncbi request reprint Effect of sustained viral response on hepatic venous pressure gradient in hepatitis C-related cirrhosis
    Stuart Roberts
    Department of Gastroenterology, Alfred Hospital, Melbourne, Victoria, Australia
    Clin Gastroenterol Hepatol 5:932-7. 2007
  8. pmc Comparison of sequence analysis and a novel discriminatory real-time PCR assay for detection and quantification of Lamivudine-resistant hepatitis B virus strains
    Fiona Wightman
    Department of Medicine, Monash University, Melbourne, Australia
    J Clin Microbiol 42:3809-12. 2004
  9. doi request reprint Drug resistance in antiviral therapy
    Stephen Locarnini
    Department of R and MD, North Melbourne, Victoria, Australia
    Clin Liver Dis 14:439-59. 2010
  10. doi request reprint Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers
    Alexander J V Thompson
    Department of Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia
    Hepatology 51:1933-44. 2010

Collaborators

Detail Information

Publications28

  1. ncbi request reprint Hepatitis B: the case for combination therapy
    Scott Bowden
    Victorian Infectious Diseases Reference Laboratory, 10 Wreckyn Street, North Melbourne, Victoria 3051, Australia
    Curr Opin Investig Drugs 10:795-803. 2009
    ....
  2. pmc Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
    Anchalee Avihingsanon
    The Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, Australia
    AIDS Res Ther 9:6. 2012
    ..abstract:..
  3. ncbi request reprint New hepatitis viruses: contenders and pretenders
    S Bowden
    Victorian Infectious Diseases Reference Laboratory, North Melbourne, Australia
    J Gastroenterol Hepatol 16:124-31. 2001
    ..However, the lessons learnt from the hepatitis virus pretenders will need to be applied to SEN-V and any future contenders...
  4. pmc New developments in HBV molecular diagnostics and quantitative serology
    D Scott Bowden
    Victorian Infectious Diseases Reference Laboratory, North Melbourne, Vic, Australia
    Hepatol Int 2:3-11. 2008
    ..A wide variety of research techniques are being used to investigate chronic hepatitis B. Further evaluation is needed to decide which will have the greatest clinical applicability...
  5. ncbi request reprint Chronic hepatitis C virus infection: genotyping and its clinical role
    D Scott Bowden
    Victorian Infectious Diseases Reference Laboratory, and Department of Microbiology, Monash University, Clayton, Carlton South, Victoria, Australia
    Future Microbiol 1:103-12. 2006
    ..The molecular basis for the differences in response of HCV genotypes has yet to be determined...
  6. doi request reprint Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia
    Tin Nguyen
    Department of Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory, North Melbourne, Vic, Australia
    J Hepatol 52:508-13. 2010
    ..We aimed to define the serum HBsAg titres during the different phases of CHB in a cohort of Asian patients infected with either genotype B or C HBV...
  7. ncbi request reprint Effect of sustained viral response on hepatic venous pressure gradient in hepatitis C-related cirrhosis
    Stuart Roberts
    Department of Gastroenterology, Alfred Hospital, Melbourne, Victoria, Australia
    Clin Gastroenterol Hepatol 5:932-7. 2007
    ..The aims of this study were to investigate the effect of treatment with peginterferon alfa-2a and ribavirin on hepatic venous pressure gradient (HVPG) in CHC with compensated cirrhosis...
  8. pmc Comparison of sequence analysis and a novel discriminatory real-time PCR assay for detection and quantification of Lamivudine-resistant hepatitis B virus strains
    Fiona Wightman
    Department of Medicine, Monash University, Melbourne, Australia
    J Clin Microbiol 42:3809-12. 2004
    ..Excellent concordance was demonstrated between sequencing and the discriminatory real-time assay; however, a mixture of quasispecies was more frequently detected by discriminatory real-time PCR...
  9. doi request reprint Drug resistance in antiviral therapy
    Stephen Locarnini
    Department of R and MD, North Melbourne, Victoria, Australia
    Clin Liver Dis 14:439-59. 2010
    ....
  10. doi request reprint Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers
    Alexander J V Thompson
    Department of Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia
    Hepatology 51:1933-44. 2010
    ..28, P = 0.01) and did not correlate with intrahepatic cccDNA nor total HBV DNA. Quantitative IHC for hepatocyte HBsAg confirmed a relationship with viral replication only in HBeAg-positive patients...
  11. doi request reprint Advances in the molecular diagnosis of hepatitis B infection: providing insight into the next generation of disease
    Julianne Bayliss
    Division of Molecular Research and Development, Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia
    Semin Liver Dis 33:113-21. 2013
    ..The authors discuss recent developments in the molecular diagnosis of HBV infection, as well as potential advantages and caveats resultant of this rapid progression of technology...
  12. pmc Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen
    David M Iser
    Department of Medicine, University of Melbourne, St Vincent s Hospital, Melbourne, Victoria, Australia
    J Virol 84:5860-7. 2010
    ....
  13. ncbi request reprint Lamivudine resistant occult HBV: implications for public health?
    Scott Bowden
    Victorian Infectious Diseases Reference Laboratory, 10 Wreckyn Street, North Melbourne, Vic 3051, Australia
    J Hepatol 38:526-8. 2003
  14. ncbi request reprint Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro
    Robert Y m Chen
    Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia
    Hepatology 37:27-35. 2003
    ..In conclusion, the PC stop codon mutation appears to increase the replication efficacy of lamivudine-resistant virus but does not affect in vitro drug sensitivity...
  15. doi request reprint Decreased viral load and symptoms of polyomavirus-associated chronic interstitial cystitis after intravesical cidofovir treatment
    Damon P Eisen
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Australia
    Clin Infect Dis 48:e86-8. 2009
    ..Another patient had milder symptoms of cystitis and intermittent polyomavirus shedding. Polyomaviruses, particularly BK virus, may cause some cases of interstitial cystitis...
  16. pmc High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study
    Rachel Sacks-Davis
    Centre for Population Health, Burnet Institute, Melbourne, Victoria, Australia Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia Centre for Excellence into Injecting Drug Use, Burnet Institute, Melbourne, Victoria, Australia
    PLoS ONE 8:e80216. 2013
    ..Public health campaigns about the risks of hepatitis C reinfection are required. ..
  17. pmc Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs
    Rachel Sacks-Davis
    Centre for Population Health, Burnet Institute, Melbourne, Victoria, Australia
    PLoS ONE 7:e47335. 2012
    ..300; p<0.001). This is the first study to show that HCV phylogeny is associated with the injecting network, highlighting the importance of the injecting network in HCV transmission...
  18. ncbi request reprint A study to investigate the impact of the initiation of highly active antiretroviral therapy on the hepatitis C virus viral load in HIV/HCV-coinfected patients
    Anne Mijch
    Department of Infectious Diseases, Alfred Hospital, Melbourne, Victoria, Australia
    Antivir Ther 10:277-84. 2005
    ..The increase in the HCV VL was not associated with hepatitis as determined by raised alanine transferase...
  19. doi request reprint TCD8 response in diverse outcomes of recurrent exposure to hepatitis C virus
    Mandvi Bharadwaj
    Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia
    Immunol Cell Biol 87:464-72. 2009
    ....
  20. ncbi request reprint Serological and molecular diagnosis
    Scott Bowden
    Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia
    Semin Liver Dis 26:97-103. 2006
    ....
  21. ncbi request reprint Quantification of HBV covalently closed circular DNA from liver tissue by real-time PCR
    Scott Bowden
    Victorian Infectious Diseases Reference Laboratory, North Melbourne, Australia
    Methods Mol Med 95:41-50. 2004
  22. doi request reprint Characterisation of single nucleotide polymorphisms in the genome of JC polyomavirus using MALDI TOF mass spectrometry
    Julianne Bayliss
    Department of Medicine, Monash University, Alfred Hospital, Victoria, Australia
    J Virol Methods 164:63-7. 2010
    ..MALDI TOF MS identified eight novel SNPs in the VP1 gene. This study represents the first application of MALDI TOF MS to viral comparative sequence analysis...
  23. ncbi request reprint Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C
    Adam Gordon
    Department of Gastroenterology, The Alfred Hospital, Victoria, Australia
    J Gastroenterol Hepatol 21:275-80. 2006
    ..The aims of this pilot study were to assess the efficacy and safety of S. marianum on serum hepatitis C virus (HCV) RNA, alanine aminotransferase levels and well-being in patients with CHC...
  24. doi request reprint GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease
    Mark D Berzsenyi
    Department of Gastroenterology, Alfred Hospital, Prahran, Victoria, Australia
    J Gastroenterol Hepatol 24:1407-10. 2009
    ..The aim of the present study was to identify the GBV-C genotype in a HCV/HIV co-infected population and determine if the GBV-C genotype contributes to a reduction in HCV-related liver disease...
  25. ncbi request reprint Molecular epidemiology of hepatitis C virus in a social network of injection drug users
    Campbell K Aitken
    Epidemiology and Social Research Program, Melbourne, Victoria, Australia
    J Infect Dis 190:1586-95. 2004
    ..We aimed to measure the overlap between the social networks of injection drug users (IDUs) and the patterns of related hepatitis C virus (HCV) infections among IDUs...
  26. ncbi request reprint Lamivudine resistance in patients with chronic hepatitis B: role of clinical and virological factors
    Alexander J V Thompson
    St Vincent s Hospital, Melbourne, Victoria, Australia
    J Gastroenterol Hepatol 22:1078-85. 2007
    ..The present study was designed to identify factors predictive of lamivudine resistance, with a particular focus on the role of precore and basal core promoter variants in the setting of hepatitis B e antigen-negative disease...
  27. ncbi request reprint GB virus C: insights into co-infection
    Mark D Berzsenyi
    Department of Gastroenterology, Alfred Hospital, Commercial Road, Prahran 3181, Victoria, Australia
    J Clin Virol 33:257-66. 2005
    ..Elucidation of the putative protective effect of GBV-C in HIV co-infection could potentially identify novel targets for anti-HIV therapeutics and lead to the development of disease modifying vaccines...
  28. ncbi request reprint Serum alanine aminotransferase levels and the detection of hepatitis C virus (HCV) in chronic HCV infections
    Heath A Kelly
    Med J Aust 176:139. 2002